immunotherapy and targeted oncology

Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs

Pancreatic cancer remains one of the deadliest cancers in India, with most cases detected too late for cure. A new mRNA vaccine is showing early promise in trials, but experts say its role, cost and real-world impact remain unclear.

A rare childhood blood cancer case highlights a shift towards personalized medicine. Instead of harsh chemotherapy, a young patient thrived on a targeted oral treatment, living a normal life years later. This innovative approach, though not universally accessible, offers hope for difficult childhood cancers, emphasizing early detection and equitable access to advanced therapies.

Immunotherapy is changing the landscape of cancer care by leveraging the body's natural defenses to combat tumors. This innovative treatment offers long-lasting benefits with reduced side effects for numerous patients; however, it may not be universally effective due to challenges like tumor evasion strategies and immune suppression.

Gastrointestinal (GI) cancers, including cancers of the colon, stomach, esophagus, pancreas, and liver, affect millions of people worldwide and remain a leading cause of mortality. Surgery, chemotherapy, and radiation therapy are the standard treatments, but immunotherapy is revolutionizing GI oncology. Immunotherapy harnesses the immune system to target cancer cells, with immune checkpoint inhibitors, T-cell therapies, oncolytic viruses, and cancer vaccines being key approaches. It offers improved response rates, fewer side effects, and long-lasting immune responses, providing hope for patients with advanced GI cancers.

German company, Merck announced it has entered into a collaboration and licensing agreement with Domain Therapeutics of France, to explore the potential of adenosine inhibition in the development of novel immuno-oncology agents.

Cancer treatment is evolving beyond a one-size-fits-all approach. Precision oncology analyzes a tumor's genetic makeup to tailor treatments, offering more effective therapies with fewer side effects. This personalized strategy aims to improve patient outcomes and provide more informed care by matching the right treatment to the right patient at the right time.

When Rohan, 12 was diagnosed with Chronic Myeloid Leukemia (CML) with a very high white blood cell count, his parents didn't opt for the traditional chemotherapy and bone marrow transplant which has serious side-effects.

City-based Mar Ivanios College and Massachusetts General Hospital (department of radiation oncology), affiliated with Harvard Medical School have entered into a research exchange agreement regarding agents targeting the tumor microenvironment (antiangiogenic or antifibrotic

The 7-minute subcutaneous injection that the UK shall soon roll out is looking like a golden moment for immunotherapy. But affordability & access in countries like India need a lot of work

Global leaders in cancer care convened in Kolkata for the GCC-EZOS 2026 conference, focusing on advancing personalized diagnosis, treatment, and prevention. The event showcased breakthroughs in genomics, AI, and immunotherapy, aiming to translate innovation into real-world patient impact. Experts discussed tailoring treatments based on individual profiles to transform cancer care.

CGP-derived insights are indispensable in managing cancer comprehensively. Oncologists will have more genomically informed data for optimal cancer treatment outcomes in the future.

India is witnessing a rapid increase in cancer cases, risking it becoming the 'Cancer Capital of the World.' While traditional treatments like chemotherapy and radiotherapy are prevalent, immunotherapy is emerging as a revolutionary option. This advanced treatment leverages the immune system to target cancer, offering hope and improved outcomes for many patients.